These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9550326)

  • 21. A monoclonal antibody with specificity to the HLA-DR1 and -DR51 antigens.
    Loh MT; Chan SH; Ren EC
    Tissue Antigens; 1993 Aug; 42(2):100-4. PubMed ID: 8266318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity.
    Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G
    Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides.
    Hsu DH; Paz P; Villaflor G; Rivas A; Mehta-Damani A; Angevin E; Zitvogel L; Le Pecq JB
    J Immunother; 2003; 26(5):440-50. PubMed ID: 12973033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
    J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro.
    Jiang S; Tugulea S; Pennesi G; Liu Z; Mulder A; Lederman S; Harris P; Cortesini R; Suciu-Foca N
    Hum Immunol; 1998 Nov; 59(11):690-9. PubMed ID: 9796737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
    Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
    Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.
    Mycko MP; Waldner H; Anderson DE; Bourcier KD; Wucherpfennig KW; Kuchroo VK; Hafler DA
    J Immunol; 2004 Aug; 173(3):1689-98. PubMed ID: 15265898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.
    Demotz S; Barbey C; Corradin G; Amoroso A; Lanzavecchia A
    Eur J Immunol; 1993 Feb; 23(2):425-32. PubMed ID: 7679644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire.
    Batten P; Heaton T; Fuller-Espie S; Lechler RI
    J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells.
    Vincent-Schneider H; Stumptner-Cuvelette P; Lankar D; Pain S; Raposo G; Benaroch P; Bonnerot C
    Int Immunol; 2002 Jul; 14(7):713-22. PubMed ID: 12096030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
    Heemskerk MH; de Paus RA; Lurvink EG; Koning F; Mulder A; Willemze R; van Rood JJ; Falkenburg JH
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6806-11. PubMed ID: 11381117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein.
    Muller CP; Ammerlaan W; Fleckenstein B; Krauss S; Kalbacher H; Schneider F; Jung G; Wiesmüller KH
    Int Immunol; 1996 Apr; 8(4):445-56. PubMed ID: 8671631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.